TITLE

Nonsteroidal Anti-Inflammatory Drugs: A survey of practices and concerns of pediatric medical and surgical specialists and a summary of available safety data

AUTHOR(S)
Levy, Deborah M.; Imundo, Lisa F.
PUB. DATE
January 2010
SOURCE
Pediatric Rheumatology;2010, Vol. 8, p7
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: To examine the prescribing habits of NSAIDs among pediatric medical and surgical practitioners, and to examine concerns and barriers to their use. Methods: A sample of 1289 pediatricians, pediatric rheumatologists, sports medicine physicians, pediatric surgeons and pediatric orthopedic surgeons in the United States and Canada were sent an email link to a 22-question webbased survey. Results: 338 surveys (28%) were completed, 84 were undeliverable. Of all respondents, 164 (50%) had never prescribed a selective cyclooxygenase-2 (COX-2) NSAID. The most common reasons for ever prescribing an NSAID were musculoskeletal pain, soft-tissue injury, fever, arthritis, fracture, and headache. Compared to traditional NSAIDs, selective COX-2 NSAIDs were believed to be as safe (42%) or safer (24%); have equal (52%) to greater efficacy (20%) for pain; have equal (59%) to greater efficacy (15%) for inflammation; and have equal (39%) to improved (44%) tolerability. Pediatric rheumatologists reported significantly more frequent abdominal pain (81% vs. 23%), epistaxis (13% vs. 2%), easy bruising (64% vs. 8%), headaches (21% vs. 1%) and fatigue (12% vs. 1%) for traditional NSAIDs than for selective COX-2 NSAIDs. Prescribing habits of NSAIDs have changed since the voluntary withdrawal of rofecoxib and valdecoxib; 3% of pediatric rheumatologists reported giving fewer traditional NSAID prescriptions, and while 57% reported giving fewer selective COX-2 NSAIDs, 26% reported that they no longer prescribed these medications. Conclusions: Traditional and selective COX-2 NSAIDs were perceived as safe by pediatric specialists. The data were compared to the published pediatric safety literature.
ACCESSION #
49130971

 

Related Articles

  • Prevence vzniku ne��douc�ch gastrointestin�ln�ch �cinku nesteroidn�ch antirevmatik pomoc� inhibitoru protonov� pumpy. V�sledky epidemiologick� studie GREAT. Forejtov�, �.; Pavelka, K.; Mare�, Z. // Czech Rheumatology / Ceska Revmatologie;Aug2011, Vol. 19 Issue 3, p104 

    The aim of our study was to survey the forms of gastroprotective therapy used in the Czech Republic during the treatment with nonsteroidal anti-rheumatic drugs (NSAIDs) in patients with chronic rheumatic diseases with different risk factors for NSAID-induced gastropathy. Methods: We conducted a...

  • Prior-authorization programs can save money--sometimes. Conlan, Michael F. // Drug Topics;7/10/95, Vol. 139 Issue 13, p73 

    Reports that prior-authorization programs for nonsteroidal anti-inflammatory drugs (NSAIDs) can save money, but more research is needed to see if effects are similar with other classes of drugs. Question of prior authorization for antidepressants and antihypersensitives; Wide use of...

  • Repeat prescribing of non-steroidal anti-inflammatory drugs excluding aspirin: how careful are we? Steele, K.; Mills, K.A.; Gilliland, A.E.W.; Irwin, W.G.; Taggart, A. // British Medical Journal (Clinical Research Edition);10/17/1987, Vol. 295 Issue 6604, p962 

    Examines the effect of repeat prescription of non-steroidal anti-inflammatory drugs in Great Britain. Adverse effects of non-steroidal anti-inflammatory drugs; Properties and cost of the drug; Guidelines in prescribing the drug.

  • NSAIDs and cardiovascular risk. Bell, Samira; Marwick, Charis A // Kidney International;Jan2014, Vol. 85 Issue 1, p211 

    A letter to the editor is presented in response to the article "Estimated GFR reporting is associated with decreased nonsteroidal anti-inflammatory drug prescribing and increased renal function," by L. Wei and colleagues in the 2013 issue.

  • Prescribing pattern of gastroprotective agents with non-steroidal anti-inflammatory drugs. Manohar, V. S.; Vinay, M.; Jayasree, T.; Kishan, P. V.; Ubedulla, S.; Dixit, Rohit // Journal of Pharmacology & Pharmacotherapeutics;Jan-Mar2013, Vol. 4 Issue 1, p59 

    A letter to the editor is presented which discusses a study on the prescribing pattern for non-steroidal anti inflammatory drugs (NSAIDs) used in orthopedics along with gastroprotectives.

  • Physicians should be cautious when prescribing diclofenac. Spitz, Sarah // CMAJ: Canadian Medical Association Journal;4/2/2013, Vol. 185 Issue 6, p470 

    The article reports on a study which reveals that the use of diclofenac increases the risk of heart attack or stroke in patients with conditions including diabetes, high cholesterol and other cardiovascular problems in Canada. The authors of the research into diclofenac, which is one of the...

  • NSAID prescriptions plunge following product withdrawal.  // Reactions Weekly;7/14/2007, Issue 1160, p4 

    The article reports on a study which found a decrease in prescriptions for nonsteroidal anti-inflammatory agents (NSAID) after the release of postmarketing safety data and the subsequent withdrawal of rofecoxib and valdecoxib from the market. Dispensing claims from a single insurance company for...

  • Clinical features and risk factors for upper gastrointestinal bleeding in children: a case-crossover study. Grimaldi-Bensouda, Lamiae; Abenhaim, Lucien; Michaud, Laurent; Mouterde, Olivier; Jonville-Béra, Annie; Giraudeau, Bruno; David, Benoît; Autret-Leca, Elisabeth // European Journal of Clinical Pharmacology;Aug2010, Vol. 66 Issue 8, p831 

    This population-based survey was conducted to provide a formal description of upper gastrointestinal bleeding (UGIB) in children on a nationwide basis and assess the contribution of risk factors, principally nonsteroidal anti-inflammatory drugs (NSAID). A case-crossover study of UGIB patients...

  • Risks and Benefits of Nonsteroidal Anti-Inflammatory Drugs in Children: A Comparison with Paracetamol. Litalien, C.; Jacqz-Aigrain, E. // Pediatric Drugs;2001, Vol. 3 Issue 11, p817 

    Nonsteroidal anti-inflammatory drugs (NSAIDs) possess antipyretic, analgesic and anti-inflammatory effects. They are frequently used in children and have numerous therapeutic indications, the most common ones being fever, postoperative pain and inflammatory disorders, such as juvenile idiopathic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics